 |
Diseases |  |
Trials |
|
Trials |  |
News |  |
- || imatinib prodrug (IkT-001Pro) / Inhibikase
Trial completion date, Trial primary completion date: A Dose Calibration Study Comparing IkT-001Pro to Imatinib Mesylate 400mg (clinicaltrials.gov) - Sep 28, 2023
P1, N=64, Recruiting, Sponsor: Inhibikase Therapeutics, Inc.
Trial completion date: Nov 2023 --> Mar 2024 | Trial primary completion date: Jun 2023 --> Dec 2023
- | imatinib prodrug (IkT-001Pro) / Inhibikase
Trial completion date: A Dose Calibration Study Comparing IkT-001Pro to Imatinib Mesylate 400mg (clinicaltrials.gov) - Mar 1, 2023
P1, N=64, Recruiting, Sponsor: Inhibikase Therapeutics, Inc.
Trial completion date: Nov 2023 --> Mar 2024 | Trial primary completion date: Jun 2023 --> Dec 2023 Trial completion date: May 2023 --> Nov 2023
- ||| imatinib prodrug (IkT-001Pro) / Inhibikase
New P1 trial: A Dose Calibration Study Comparing IkT-001Pro to Imatinib Mesylate 400mg (clinicaltrials.gov) - Nov 21, 2022
P1, N=64, Recruiting, Sponsor: Inhibikase Therapeutics, Inc.